Cell and biomolecule delivery for tissue repair and regeneration in the central nervous system

Journal of Controlled Release

Volumn 190, Issue , 2014, Pages 219-227

  Elliott Donaghue, Irja ^a   Tam, Roger ^a   Sefton, Michael V ^a   Shoichet, Molly S ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Biomaterial drug delivery; Spinal cord injury; Stem cell transplantation; Tissue engineering; Traumatic brain injury

Indexed keywords

BIOMOLECULES; BRAIN; CELL CULTURE; DRUG DELIVERY; NEUROPHYSIOLOGY; REPAIR; STEM CELLS; TISSUE; TISSUE ENGINEERING; TISSUE REGENERATION; SCAFFOLDS (BIOLOGY);

BIOMOLECULE DELIVERIES; CENTRAL NERVOUS SYSTEMS; COMBINATION STRATEGIES; ENCAPSULATED CELL THERAPIES; NEURAL STEM/PROGENITOR CELLS; SPINAL CORD INJURIES (SCI); STEM CELL TRANSPLANTATION; TRAUMATIC BRAIN INJURIES;

SCAFFOLDS (BIOLOGY); CELL ENGINEERING;

BIOMATERIAL; HYALURONIC ACID; METHYLCELLULOSE; MICROSPHERE; NANOSPHERE; POLYGLACTIN; TISSUE SCAFFOLD; DELAYED RELEASE FORMULATION; DRUG CARRIER; HYDROGEL; NANOPARTICLE; POLYMER;

CELL ENCAPSULATION; CELL FUNCTION; CELL STIMULATION; CENTRAL NERVOUS SYSTEM DISEASE; CONTROLLED DRUG RELEASE; DRUG DELIVERY SYSTEM; ENGRAFTMENT; HUMAN; HYDROGEL; MESENCHYMAL STEM CELL TRANSPLANTATION; MODULATION; NERVE REGENERATION; NERVOUS SYSTEM INFLAMMATION; NEURAL STEM CELL TRANSPLANTATION; NONHUMAN; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING; TISSUE REGENERATION; TISSUE REPAIR; CENTRAL NERVOUS SYSTEM; DELAYED RELEASE FORMULATION; DRUG EFFECTS; PHYSIOLOGY; PROCEDURES; REGENERATION; ALZHEIMER DISEASE; BLOOD BRAIN BARRIER; CELL DEATH; CELL THERAPY; CELL VIABILITY; CEREBROVASCULAR ACCIDENT; DRUG FORMULATION; EXTRACELLULAR MATRIX; IMPLANT; MULTIPLE SCLEROSIS; NERVE SPROUTING; PROTEIN DEGRADATION; SPINAL CORD INJURY; TISSUE DEGENERATION; TRAUMATIC BRAIN INJURY;

CENTRAL NERVOUS SYSTEM; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HUMANS; HYDROGEL; MICROSPHERES; NANOPARTICLES; NERVE REGENERATION; POLYMERS; REGENERATION; TISSUE ENGINEERING;

EID: 84906784014     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2014.05.040     Document Type: Review

References (138)

1. F. Lim, and A.M. Sun Microencapsulated islets in diabetic rats Science 213 1981 1146
2. J.R. Nixon Microencapsulation 1976 M Dekker New York
3. W.L. Chick, A.A. Like, and V. Lauris et al. Hybrid artificial pancreas Trans. Am. Soc. Artif. Intern. Organs 21 1975 8 15
4. H.M. Creque, R. Langer, and J. Folkman One month of sustained-release of insulin from a polymer implant Diabetes 29 1980 37 40 (Pubitemid 10157187)
5. A.M. Albisser, B.S. Leibel, and T.G. Ewart et al. An artificial endocrine pancreas Diabetes 23 1974 389 396
6. H. Shamoon, H. Duffy, and N. Fleischer et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes-mellitus N. Engl. J. Med. 329 1993 977 986 (Pubitemid 23307905)
7. J. Kost, T.A. Horbett, and B.D. Ratner et al. Glucose-sensitive membranes containing glucose-oxidase - activity, swelling, and permeability studies J. Biomed. Mater. Res. 19 1985 1117 1133 (Pubitemid 16214582)
8. H. Thurow, and K. Geisen Stabilization of dissolved proteins against denaturation at hydrophobic interfaces Diabetologia 27 1984 212 218 (Pubitemid 14067460)
9. M.E. Sugamori, and M.V. Sefton Microencapsulation of pancreatic islets in a water insoluble polyacrylate ASAIO Trans. 35 1989 791 799 (Pubitemid 20055041)
10. H. Uludag, V. Horvath, and J.P. Black et al. Viability and protein secretion from human hepatoma (Hepg2) cells encapsulated in 400 μm polyacrylate microcapsules by submerged nozzle liquid jet extrusion Biotech. Bioeng. 44 1994 1199 1204
11. D.W. Scharp, and P. Marchetti Encapsulated islets for diabetes therapy: history, current progress, and critical issues requiring solution Adv. Drug Deliv. Rev. 67-68 2013 35 73
12. E.G. Campioni, J.N. Nobrega, and M.V. Sefton HEMA/MMMA microcapsule implants in hemiparkinsonian rat brain: biocompatibility assessment using [3H]PK11195 as a marker for gliosis Biomaterials 19 1998 829 837 (Pubitemid 28276634)
13. J.J. Vallbacka, J.N. Nobrega, and M.V. Sefton Tissue engineering as a platform for controlled release of therapeutic agents: implantation of microencapsulated dopamine producing cells in the brains of rats J. Control. Release 72 2001 93 100 (Pubitemid 32522347)
14. T. Roberts, U. De Boni, and M.V. Sefton Dopamine secretion by PC12 cells microencapsulated in a hydroxyethyl methacrylate-methyl methacrylate copolymer Biomaterials 17 1996 267 275 (Pubitemid 26031380)
15. P. Aebischer, G. Panol, and P.M. Galletti An intraperitoneal receptacle for macroencapsulated endocrine tissue ASAIO Trans. 32 1986 130 133
16. P. Aebischer, N.A.M. Pochon, and B. Heyd et al. Gene therapy for amyotrophic lateral sclerosis (ALS) using a polymer encapsulated xenogenic cell line engineered to secrete hCNTF Hum. Gene Ther. 7 1996 851 860 (Pubitemid 26146442)
17. H. Kim, T. Zahir, and C.H. Tator et al. Effects of dibutyryl cyclic-AMP on survival and neuronal differentiation of neural stem/progenitor cells transplanted into spinal cord injured rats PLoS One 6 2011
18. J.P. Vacanti, M.A. Morse, and W.M. Saltzman et al. Selective cell transplantation using bioabsorbable artificial polymers as matrices J. Pediatr. Surg. 23 1988 3 9 (Pubitemid 18061300)
19. C.A. Vacanti, R. Langer, and B. Schloo et al. Synthetic-polymers seeded with chondrocytes provide a template for new cartilage formation Plast. Reconstr. Surg. 88 1991 753 759
20. L.G. Cima, J.P. Vacanti, and C. Vacanti et al. Tissue engineering by cell transplantation using degradable polymer substrates J. Biomech. Eng. Trans. ASME 113 1991 143 151
21. J.C.Y. Dunn, R.G. Tompkins, and M.L. Yarmush Long-term in vitro function of adult hepatocytes in a collagen sandwich configuration Biotechnol. Prog. 7 1991 237 245
22. A. Khademhosseini, J.P. Vacanti, and R. Langer Progress in tissue engineering Sci. Am. 300 2009 (64-+)
23. J. Rouwkema, N.C. Rivron, and C.A. van Blitterswijk Vascularization in tissue engineering Trends Biotechnol. 26 2008 434 441
24. M.W. Tibbitt, and K.S. Anseth Dynamic microenvironments: the fourth dimension Sci. Transl. Med. 4 2012
25. M.V. Sefton, J.E. Babensee, and K.A. Woodhouse Innate and adaptive immune responses in tissue engineering Semin. Immunol. 20 2008 83 85
26. P.C. Johnson, A.G. Mikos, and J.P. Fisher et al. Strategic directions in tissue engineering Tissue Eng. 13 2007 (2827-+)
27. J.C. DiNunzio, and R.O. Williams CNS disorders - current treatment options and the prospects for advanced therapies Drug Dev. Ind. Pharm. 34 2008 1141 1167
28. M. Cully Drug development: chemical brace Nature 503 2013 S10 S12
29. A. Rogalewski, A. Schneider, and E.B. Ringelstein et al. Toward a multimodal neuroprotective treatment of stroke Stroke 37 2006 1129 1136
30. F.-M. Chen, M. Zhang, and Z.-F. Wu Toward delivery of multiple growth factors in tissue engineering Biomaterials 31 2010 6279 6308
31. E.A.J. Joosten, P.R. Bar, and W.H. Gispen Collagen implants and corticospinal axonal growth after mid-thoracic spinal-cord lesion in the adult-rat J. Neurosci. Res. 41 1995 481 490
32. X.G. Li, Z.Y. Yang, and A.F. Zhang et al. Repair of thoracic spinal cord injury by chitosan tube implantation in adult rats Biomaterials 30 2009 1121 1132
33. P.J. Johnson, S.R. Parker, and S.E. Sakiyama-Elbert Fibrin-based tissue engineering scaffolds enhance neural fiber sprouting and delay the accumulation of reactive astrocytes at the lesion in a subacute model of spinal cord injury J. Biomed. Mater. Res. A 92A 2010 152 163
34. J.W. Austin, C.E. Kang, and M.D. Baumann et al. The effects of intrathecal injection of a hyaluronan-based hydrogel on inflammation, scarring and neurobehavioural outcomes in a rat model of severe spinal cord injury associated with arachnoiditis Biomaterials 33 2012 4555 4564
35. D. Gupta, C.H. Tator, and M.S. Shoichet Fast-gelling injectable blend of hyaluronan and methylcellulose for intrathecal, localized delivery to the injured spinal cord Biomaterials 27 2006 2370 2379 (Pubitemid 41821815)
36. S.P. Hou, Q.Y. Xu, and W.M. Tian et al. The repair of brain lesion by implantation of hyaluronic acid hydrogels modified with laminin J. Neurosci. Methods 148 2005 60 70
37. Y.T. Wei, W.M. Tian, and X. Yu et al. Hyaluronic acid hydrogels with IKVAV peptides for tissue repair and axonal regeneration in an injured rat brain Biomed. Mater. 2 2007 S142 S146
38. R.G. Ellis-Behnke, Y.X. Liang, and S.W. You et al. Nano neuro knitting: peptide nanofiber scaffold for brain repair and axon regeneration with functional return of vision Proc. Natl. Acad. Sci. U.S.A. 103 2006 5054 5059
39. V.M. Tysseling-Mattiace, V. Sahni, and K.L. Niece et al. Self-assembling nanofibers inhibit glial scar formation and promote axon elongation after spinal cord injury J. Neurosci. 28 2008 3814 3823
40. V.M. Tysseling, V. Sahni, and E.T. Pashuck et al. Self-assembling peptide amphiphile promotes plasticity of serotonergic fibers following spinal cord injury J. Neurosci. Res. 88 2010 3161 3170
41. P. Lu, and M.H. Tuszynski Growth factors and combinatorial therapies for CNS regeneration Exp. Neurol. 209 2008 313 320 (Pubitemid 351174138)
42. L. Schnell, R. Schneider, and R. Kolbeck et al. Neurotrophin-3 enhances sprouting of corticospinal tract during development and after adult spinal-cord lesion Nature 367 1994 170 173 (Pubitemid 24031697)
43. E.J. Bradbury, L.D.F. Moon, and R.J. Popat et al. Chondroitinase ABC promotes functional recovery after spinal cord injury Nature 416 2002 636 640 (Pubitemid 34406764)
44. L.L. Jones, and M.H. Tuszynski Chronic intrathecal infusions after spinal cord injury cause scarring and compression Microsc. Res. Tech. 54 2001 317 324 (Pubitemid 32803846)
45. K.A. Follett, R.L. Boortz-Marx, and J.M. Drake et al. Prevention and management of intrathecal drug delivery and spinal cord stimulation system infections Anesthesiology 100 2004 1582 1594 (Pubitemid 38679330)
46. L.B. Jakeman, P. Wei, and Z. Guan et al. Brain-derived neurotrophic factor stimulates hindlimb stepping and sprouting of cholinergic fibers after spinal cord injury Exp. Neurol. 154 1998 170 184 (Pubitemid 28553577)
47. E.J. Bradbury, S. Khemani, and V.R. King et al. NT-3 promotes growth of lesioned adult rat sensory axons ascending in the dorsal columns of the spinal cord Eur. J. Neurosci. 11 1999 3873 3883 (Pubitemid 29537567)
48. T. GrandPre, S.X. Li, and S.M. Strittmatter Nogo-66 receptor antagonist peptide promotes axonal regeneration Nature 417 2002 547 551 (Pubitemid 34595921)
49. S.X. Li, and S.M. Strittmatter Delayed systemic Nogo-66 receptor antagonist promotes recovery from spinal cord injury J. Neurosci. 23 2003 4219 4227 (Pubitemid 36958442)
50. B.X. Ji, M.W. Li, and S. Budel et al. Effect of combined treatment with methylprednisolone and soluble Nogo-66 receptor after rat spinal cord injury Eur. J. Neurosci. 22 2005 587 594 (Pubitemid 41192269)
51. R.-R. Zhao, M.R. Andrews, and D. Wang et al. Combination treatment with anti-Nogo-A and chondroitinase ABC is more effective than single treatments at enhancing functional recovery after spinal cord injury Eur. J. Neurosci. 38 2013 2946 2961
52. T. Kobayashi, H. Ahlenius, and P. Thored et al. Intracerebral infusion of glial cell line-derived neurotrophic factor promotes striatal neurogenesis after stroke in adult rats Stroke 37 2006 2361 2367 (Pubitemid 44337184)
53. B. Kolb, C. Morshead, and C. Gonzalez et al. Growth factor-stimulated generation of new cortical tissue and functional recovery after stroke damage to the motor cortex of rats J. Cereb. Blood Flow Metab. 27 2007 983 997 (Pubitemid 46659027)
54. M. Kinoshita, N. McDannold, and F.A. Jolesz et al. Targeted delivery of antibodies through the blood-brain barrier by MRI-guided focused ultrasound Biochem. Biophys. Res. Commun. 340 2006 1085 1090 (Pubitemid 43083389)
55. J.F. Jordao, E. Thevenot, and K. Markham-Coultes et al. Amyloid-beta plaque reduction, endogenous antibody delivery and glial activation by brain-targeted, transcranial focused ultrasound Exp. Neurol. 248 2013 16 29
56. A. Burgess, and K. Hynynen Noninvasive and targeted drug delivery to the brain using focused ultrasound ACS Chem. Neurosci. 4 2013 519 526
57. Y. Zhang, and W.M. Pardridge Conjugation of brain-derived neurotrophic factor to a blood-brain barrier drug targeting system enables neuroprotection in regional brain ischemia following intravenous injection of tbe neurotrophin Brain Res. 889 2001 49 56 (Pubitemid 32146264)
58. Y. Zhang, and W.M. Pardridge Neuroprotection in transient focal brain ischemia after delayed intravenous administration of brain-derived neurotrophic factor conjugated to a blood-brain barrier drug targeting system Stroke 32 2001 1378 1383 (Pubitemid 32530426)
59. B.W. Song, H.V. Vinters, and D.F. Wu et al. Enhanced neuroprotective effects of basic fibroblast growth factor in regional brain ischemia after conjugation to a blood-brain barrier delivery vector J. Pharmacol. Exp. Ther. 301 2002 605 610 (Pubitemid 34429974)
60. Y. Zhang, and W.M. Pardridge Blood-brain barrier targeting of BDNF improves motor function in rats with middle cerebral artery occlusion Brain Res. 1111 2006 227 229 (Pubitemid 44339581)
61. R.J. Boado, Y. Zhang, and Y. Zhang et al. GDNF fusion protein for targeted-drug delivery across the human blood-brain barrier Biotech. Bioeng. 100 2008 387 396 (Pubitemid 351758180)
62. A.L. Fu, E.K.W. Hui, and J.Z. Lu et al. Neuroprotection in experimental stroke in the rat with an IgG-erythropoietin fusion protein Brain Res. 1360 2010 193 197
63. R.K. Sumbria, R.J. Boado, and W.M. Pardridge Combination stroke therapy in the mouse with blood-brain barrier penetrating IgG-GDNF and IgG-TNF decoy receptor fusion proteins Brain Res. 1507 2013 91 96
64. J.P. Zhou, Z.G. Feng, and B.L. Yuan et al. Transduced PTD-BDNF fusion protein protects against beta amyloid peptide-induced learning and memory deficits in mice Brain Res. 1191 2008 12 19
65. G. Bertilsson, C. Patrone, and O. Zachrisson et al. Peptide hormone exendin-4 stimulates subventricular zone neurogenesis in the adult rodent brain and induces recovery in an animal model of Parkinson's disease J. Neurosci. Res. 86 2008 326 338 (Pubitemid 351196738)
66. I. Aviles-Olmos, J. Dickson, and Z. Kefalopoulou et al. Exenatide and the treatment of patients with Parkinson's disease J. Clin. Invest. 123 2013 2730 2736
67. P. Menei, V. Daniel, and C. Monteromenei et al. Biodegradation and brain-tissue reaction to poly(d, l-lactide-co-glycolide) microspheres Biomaterials 14 1993 470 478 (Pubitemid 23164191)
68. A.P. Nicholas, C. McInnis, and K.B. Gupta et al. The fate of biodegradable microspheres injected into rat brain Neurosci. Lett. 323 2002 85 88 (Pubitemid 34310246)
69. J.M. Pean, P. Menei, and O. Morel et al. Intraseptal implantation of NGF-releasing microspheres promote the survival of axotomized cholinergic neurons Biomaterials 21 2000 2097 2101 (Pubitemid 30488081)
70. C. Jollivet, A. Aubert-Pouessel, and A. Clavreul et al. Striatal implantation of GDNF releasing biodegradable microspheres promotes recovery of motor function in a partial model of Parkinson's disease Biomaterials 25 2004 933 942 (Pubitemid 37376418)
71. C. Jollivet, A. Aubert-Pouessel, and A. Clavreul et al. Long-term effect of intra-striatal glial cell line-derived neurotrophic factor-releasing microspheres in a partial rat model of Parkinson's disease Neurosci. Lett. 356 2004 207 210 (Pubitemid 38186688)
72. C. Andrieu-Soler, A. Aubert-Pouessel, and M. Doat et al. Intravitreous injection of PLGA microspheres encapsulating GDNF promotes the survival of photoreceptors in the rd1/rd1 mouse Mol. Vis. 11 2005 1002 1011 (Pubitemid 41715739)
73. E. Garbayo, C.N. Montero-Menei, and E. Ansorena et al. Effective GDNF brain delivery using microspheres - a promising strategy for Parkinson's disease J. Control. Release 135 2009 119 126
74. M.S. Ward, A. Khoobehi, and E.B. Lavik et al. Neuroprotection of retinal ganglion cells in DBA/2J mice with GDNF-loaded biodegradable microspheres J. Pharm. Sci. 96 2007 558 568 (Pubitemid 46466078)
75. C. Jiang, M.J. Moore, and X. Zhang et al. Intravitreal injections of GDNF-loaded biodegradable microspheres are neuroprotective in a rat model of glaucoma Mol. Vis. 13 2007 1783 1792 (Pubitemid 47497006)
76. P. Checa-Casalengua, C. Jiang, and I. Bravo-Osuna et al. Retinal ganglion cells survival in a glaucoma model by GDNF/Vit E PLGA microspheres prepared according to a novel microencapsulation procedure J. Control. Release 156 2011 92 100
77. N. Lowry, S.K. Goderie, and P. Lederman et al. The effect of long-term release of Shh from implanted biodegradable microspheres on recovery from spinal cord injury in mice Biomaterials 33 2012 2892 2901
78. Y.-C. Wang, Y.-T. Wu, and H.-Y. Huang et al. Sustained intraspinal delivery of neurotrophic factor encapsulated in biodegradable nanoparticles following contusive spinal cord injury Biomaterials 29 2008 4546 4553
79. S.R. Cerqueira, J.M. Oliveira, and N.A. Silva et al. Microglia response and in vivo therapeutic potential of methylprednisolone-loaded dendrimer nanoparticles in spinal cord injury Small 9 2012 738 749
80. E.A. Nance, G.F. Woodworth, and K.A. Sailor et al. A dense poly(ethylene glycol) coating improves penetration of large polymeric nanoparticles within brain tissue Sci. Transl. Med. 4 2012
81. H. Gao, Z. Pang, and X. Jiang Targeted delivery of nano-therapeutics for major disorders of the central nervous system Pharm. Res. 30 2013 2485 2498
82. M. Nof, and L.D. Shea Drug-releasing scaffolds fabricated from drug-loaded microspheres J. Biomed. Mater. Res. 59 2002 349 356
83. W.M. Tian, C.L. Zhang, and S.P. Hou et al. Hyaluronic acid hydrogel as Nogo-66 receptor antibody delivery system for the repairing of injured rat brain: in vitro J. Control. Release 102 2005 13 22 (Pubitemid 40093772)
84. Y. Yang, L. De Laporte, and C.B. Rives et al. Neurotrophin releasing single and multiple lumen nerve conduits J. Control. Release 104 2005 433 446 (Pubitemid 40724940)
85. L. De Laporte, A.L. Yan, and L.D. Shea Local gene delivery from ECM-coated poly(lactide-co-glycolide) multiple channel bridges after spinal cord injury Biomaterials 30 2009 2361 2368
86. L. Yao, W. Daly, and B. Newland et al. Improved axonal regeneration of transected spinal cord mediated by multichannel collagen conduits functionalized with neurotrophin-3 gene Gene Ther. 20 2013 1149 1157
87. S. Stokols, and M.H. Tuszynski Freeze-dried agarose scaffolds with uniaxial channels stimulate and guide linear axonal growth following spinal cord injury Biomaterials 27 2006 443 451 (Pubitemid 41457247)
88. A. Bakshi, O. Fisher, and T. Dagci et al. Mechanically engineered hydrogel scaffolds for axonal growth and angiogenesis after transplantation in spinal cord injury J. Neurosurg. Spine 1 2004 322 329
89. Q. Han, W. Sun, and H. Lin et al. Linear ordered collagen scaffolds loaded with collagen-binding brain-derived neurotrophic factor improve the recovery of spinal cord injury in rats Tissue Eng. A 15 2009 2927 2935
90. L. De Laporte, Y. Yang, and M.L. Zelivyanskaya et al. Plasmid releasing multiple channel bridges for transgene expression after spinal cord injury Mol. Ther. 17 2009 318 326
91. H.M. Tuinstra, M.O. Aviles, and S. Shin et al. Multifunctional, multichannel bridges that deliver neurotrophin encoding lentivirus for regeneration following spinal cord injury Biomaterials 33 2012 1618 1626
92. J. Ma, W.-M. Tian, and S.-P. Hou et al. An experimental test of stroke recovery by implanting a hyaluronic acid hydrogel carrying a Nogo receptor antibody in a rat model Biomed. Mater. 2 2007 233 240 (Pubitemid 350215864)
93. Y.-T. Wei, Y. He, and C.-L. Xu et al. Hyaluronic acid hydrogel modified with nogo-66 receptor antibody and poly-(l)-lysine to promote axon regrowth after spinal cord injury J. Biomed. Mater. Res. B Appl. Biomater. 95B 2010 110 117
94. M.M. Pakulska, B.G. Ballios, and M.S. Shoichet Injectable hydrogels for central nervous system therapy Biomed. Mater. 7 2012
95. S.E. Sakiyama-Elbert, and J.A. Hubbell Development of fibrin derivatives for controlled release of heparin-binding growth factors J. Control. Release 65 2000 389 402 (Pubitemid 30122941)
96. S.J. Taylor, J.W. McDonald, and S.E. Sakiyama-Elbert Controlled release of neurotrophin-3 from fibrin gels for spinal cord injury J. Control. Release 98 2004 281 294 (Pubitemid 38950737)
97. S.J. Taylor, E.S. Rosenzweig, and J.W. McDonald III et al. Delivery of neurotrophin-3 from fibrin enhances neuronal fiber sprouting after spinal cord injury J. Control. Release 113 2006 226 235 (Pubitemid 43963190)
98. S.J. Taylor, and S.E. Sakiyama-Elbert Effect of controlled delivery of neurotrophin-3 from fibrin on spinal cord injury in a long term model J. Control. Release 116 2006 204 210 (Pubitemid 44854282)
99. P.J. Johnson, S.R. Parker, and S.E. Sakiyama-Elbert Controlled release of neurotrophin-3 from fibrin-based tissue engineering scaffolds enhances neural fiber sprouting following subacute spinal cord injury Biotech. Bioeng. 104 2009 1207 1214
100. A.J.T. Hyatt, D. Wang, and J.C. Kwok et al. Controlled release of chondroitinase ABC from fibrin gel reduces the level of inhibitory glycosaminoglycan chains in lesioned spinal cord J. Control. Release 147 2010 24 29
101. S. Lord-Fontaine, F. Yang, and Q. Diep et al. Local inhibition of Rho signaling by cell-permeable recombinant protein BA-210 prevents secondary damage and promotes functional recovery following acute spinal cord injury J. Neurotrauma 25 2008 1309 1322
102. J.R. Wilson, N. Forgione, and M.G. Fehlings Emerging therapies for acute traumatic spinal cord injury Can. Med. Assoc. J. 185 2013 485 492
103. M.G. Fehlings, N. Theodore, and J. Harrop et al. Phase I/IIa clinical trial of a recombinant Rho protein antagonist in acute spinal cord injury J. Neurotrauma 28 2011 787 796
104. L. McKerracher, and K.D. Anderson Analysis of recruitment and outcomes in the phase I/IIa cethrin clinical trial for acute spinal cord injury J. Neurotrauma 30 2013 1795 1804
105. A. Jain, Y.T. Kim, and R.J. McKeon et al. In situ gelling hydrogels for conformal repair of spinal cord defects, and local delivery of BDNF after spinal cord injury Biomaterials 27 2006 497 504 (Pubitemid 41457252)
106. H. Lee, R.J. McKeon, and R.V. Bellamkonda Sustained delivery of thermostabilized chABC enhances axonal sprouting and functional recovery after spinal cord injury Proc. Natl. Acad. Sci. U.S.A. 107 2010 3340 3345
107. S. Mehrotra, D. Lynam, and R. Maloney et al. Time controlled protein release from layer-by-layer assembled multilayer functionalized agarose hydrogels Adv. Funct. Mater. 20 2010 247 258
108. S. Mehrotra, D. Lynam, and C. Liu et al. Time controlled release of arabinofuranosylcytosine (Ara-C) from agarose hydrogels using layer-by-layer assembly: an in vitro study J. Biomater. Sci. Polym. Ed. 23 2012 439 463
109. M.C.J. Hamann, C.H. Tator, and M.S. Shoichet Injectable intrathecal delivery system for localized administration of EGF and FGF-2 to the injured rat spinal cord Exp. Neurol. 194 2005 106 119 (Pubitemid 40719747)
110. C.E. Kang, R. Clarkson, and C.H. Tator et al. Spinal cord blood flow and blood vessel permeability measured by dynamic computed tomography imaging in rats after localized delivery of fibroblast growth factor J. Neurotrauma 27 2010 2041 2053
111. M.J. Cooke, Y. Wang, and C.M. Morshead et al. Controlled epi-cortical delivery of epidermal growth factor for the stimulation of endogenous neural stem cell proliferation in stroke-injured brain Biomaterials 32 2011 5688 5697
112. C.E. Kang, P.C. Poon, and C.H. Tator et al. A new paradigm for local and sustained release of therapeutic molecules to the injured spinal cord for neuroprotection and tissue repair Tissue Eng. A 15 2009 595 604
113. Y. Wang, M.J. Cooke, and C.M. Morshead et al. Hydrogel delivery of erythropoietin to the brain for endogenous stem cell stimulation after stroke injury Biomaterials 33 2012 2681 2692
114. R.H. Bobo, D.W. Laske, and A. Akbasak et al. Convection-enhanced delivery of macromolecules in the brain Proc. Natl. Acad. Sci. U.S.A. 91 1994 2076 2080 (Pubitemid 24092045)
115. A.J. Sawyer, J.M. Piepmeier, and W.M. Saltzman New methods for direct delivery of chemotherapy for treating brain tumors Yale J. Biol. Med. 79 2006 141 152
116. J.A. Burdick, M. Ward, and E. Liang et al. Stimulation of neurite outgrowth by neurotrophins delivered from degradable hydrogels Biomaterials 27 2006 452 459 (Pubitemid 41457248)
117. J. Piantino, J.A. Burdick, and D. Goldberg et al. An injectable, biodegradable hydrogel for trophic factor delivery enhances axonal rewiring and improves performance after spinal cord injury Exp. Neurol. 201 2006 359 367 (Pubitemid 44344229)
118. L.C. Grous, J. Vernengo, and Y. Jin et al. Implications of poly(N-isopropylacrylamide)-g-poly(ethylene glycol) with codissolved brain-derived neurotrophic factor injectable scaffold on motor function recovery rate following cervical dorsolateral funiculotomy in the rat J. Neurosurg. Spine 18 2013 641 652
119. B. Song, J. Song, and S. Zhang et al. Sustained local delivery of bioactive nerve growth factor in the central nervous system via tunable diblock copolypeptide hydrogel depots Biomaterials 33 2012 9105 9116
120. K. Vulic, and M.S. Shoichet Tunable growth factor delivery from injectable hydrogels for tissue engineering J. Am. Chem. Soc. 134 2012 882 885
121. M.M. Pakulska, K. Vulic, and M.S. Shoichet Affinity-based release of chondroitinase ABC from a modified methylcellulose hydrogel J. Control. Release 171 2013 11 16
122. K.J. Lampe, D.S. Kern, and M.J. Mahoney et al. The administration of BDNF and GDNF to the brain via PLGA microparticles patterned within a degradable PEG-based hydrogel: protein distribution and the glial response J. Biomed. Mater. Res. A 96A 2011 595 607
123. Y.T. Kim, J.M. Caldwell, and R.V. Bellamkonda Nanoparticle-mediated local delivery of methylprednisolone after spinal cord injury Biomaterials 30 2009 2582 2590
124. E. Ansorena, P. De Berdt, and B. Ucakar et al. Injectable alginate hydrogel loaded with GDNF promotes functional recovery in a hemisection model of spinal cord injury Int. J. Pharm. 455 2013 148 158
125. C.E. Kang, M.D. Baumann, and C.H. Tator et al. Localized and sustained delivery of fibroblast growth factor-2 from a nanoparticle-hydrogel composite for treatment of spinal cord injury Cells Tissues Organs 197 2012 55 63
126. M.J. Caicco, M.J. Cooke, and Y.F. Wang et al. A hydrogel composite system for sustained epi-cortical delivery of cyclosporin A to the brain for treatment of stroke J. Control. Release 166 2012 197 202
127. Y. Wang, M.J. Cooke, and N. Sachewsky et al. Bioengineered sequential growth factor delivery stimulates brain tissue regeneration after stroke J. Control. Release 172 2013 1
128. J.C. Stanwick, M.D. Baumann, and M.S. Shoichet Enhanced neurotrophin-3 bioactivity and release from a nanoparticle-loaded composite hydrogel J. Control. Release 160 2012 666 675
129. J.C. Stanwick, M.D. Baumann, and M.S. Shoichet In vitro sustained release of bioactive anti-NogoA, a molecule in clinical development for treatment of spinal cord injury Int. J. Pharm. 426 2012 284 290
130. N.D. Leipzig, and M.S. Shoichet The effect of substrate stiffness on adult neural stem cell behavior Biomaterials 30 2009 6867 6878
131. Y. Aizawa, N. Leipzig, and T. Zahir et al. The effect of immobilized platelet derived growth factor AA on neural stem/progenitor cell differentiation on cell-adhesive hydrogels Biomaterials 29 2008 4676 4683
132. T.Y. Wang, J.S. Forsythe, and D.R. Nisbet et al. Promoting engraftment of transplanted neural stem cells/progenitors using biofunctionalised electrospun scaffolds Biomaterials 33 2012 9188 9197
133. T.Y. Cheng, M.H. Chen, and W.H. Chang et al. Neural stem cells encapsulated in a functionalized self-assembling peptide hydrogel for brain tissue engineering Biomaterials 34 2013 2005 2016
134. A.J. Mothe, R.Y. Tam, and T. Zahir et al. Repair of the injured spinal cord by transplantation of neural stem cells in a hyaluronan-based hydrogel Biomaterials 34 2013 3775 3783
135. P.J. Johnson, A. Tatara, and A. Shiu et al. Controlled release of neurotrophin-3 and platelet-derived growth factor from fibrin scaffolds containing neural progenitor cells enhances survival and differentiation into neurons in a subacute model of SCI Cell Transplant. 19 2010 89 101
136. E. Bible, O. Qutachi, and D.Y.S. Chau et al. Neo-vascularization of the stroke cavity by implantation of human neural stem cells on VEGF-releasing PLGA microparticles Biomaterials 33 2012 (7435-+)
137. G.J.R. Delcroix, E. Garbayo, and L. Sindji et al. The therapeutic potential of human multipotent mesenchymal stromal cells combined with pharmacologically active microcarriers transplanted in hemi-parkinsonian rats Biomaterials 32 2011 1560 1573
138. D. Matsuse, M. Kitada, and F. Ogura et al. Combined transplantation of bone marrow stromal cell-derived neural progenitor cells with a collagen sponge and basic fibroblast growth factor releasing microspheres enhances recovery after cerebral ischemia in rats Tissue Eng. A 17 2011 1993 2004